We are live on ! Find out more
ROIV icon

Roivant Sciences
ROIV

71 hedge funds and large institutions have $1.47B invested in Roivant Sciences in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 22 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 4

173% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 11

37% more funds holding

Funds holding: 52 → 71 (+19)

0.99% more ownership

Funds ownership: 50.45% → 51.44% (+0.99%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

15% less capital invested

Capital invested by funds: $1.72B → $1.47B (-$258M)

28% less call options, than puts

Call options by funds: $257K | Put options by funds: $355K

Holders
71
Holders Change
+19
Holders Change %
+36.54%
% of All Funds
1.2%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
30
Increased
22
Reduced
4
Closed
11
Calls
$257K
Puts
$355K
Net Calls
-$98K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
TSC
Two Seas Capital
New York
+$10.4M
2
BlackRock
BlackRock
New York
+$5.49M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.97M
4
CC
Chicago Capital
Illinois
+$3.72M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.48M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$693K
2
Squarepoint
Squarepoint
New York
-$354K
3
OQS
Occudo Quantitative Strategies
Florida
-$320K
4
Two Sigma Investments
Two Sigma Investments
New York
-$248K
5
Jane Street
Jane Street
New York
-$246K
Name Holding Trade Value Shares
Change 		Change in
Stake
QF
1
QVT Financial
New York
$527M – – –
SIAU
2
SB Investment Advisers (UK)
United Kingdom
$404M – – –
Viking Global Investors
3
Viking Global Investors
Connecticut
$359M – – –
BlackRock
4
BlackRock
New York
$22.1M +$5.49M +1,383,639 +34%
HH
5
HSG Holding
Hong Kong
$21.2M +$998K +251,434 +5%
ACG
6
Anchorage Capital Group
New York
$19.7M – – –
TSC
7
Two Seas Capital
New York
$13.9M +$10.4M +2,612,929 +324%
PT
8
Palantir Technologies
Colorado
$12.2M – – –
Fidelity Investments
9
Fidelity Investments
Massachusetts
$10.2M – – –
AIG
10
American International Group
New York
$7.39M – – –
EAM
11
Eventide Asset Management
Massachusetts
$6.74M – – –
Vanguard Group
12
Vanguard Group
Pennsylvania
$6.17M +$781K +196,850 +15%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$5.63M +$374K +94,293 +7%
FFVM
14
Founders Fund VI Management
California
$4.56M – – –
State Street
15
State Street
Massachusetts
$4.46M +$2.58M +649,000 +145%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$4.07M +$3.97M +1,000,000 New
CC
17
Chicago Capital
Illinois
$3.82M +$3.72M +938,113 New
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$3.57M +$3.48M +876,996 New
RI
19
RTW Investments
New York
$3.27M – – –
Charles Schwab
20
Charles Schwab
California
$2.9M -$41.1K -10,363 -1%
SCM
21
Suvretta Capital Management
New York
$2.77M – – –
Swiss National Bank
22
Swiss National Bank
Switzerland
$2.65M +$2.59M +652,046 New
PIM
23
Platinum Investment Management
Australia
$2.06M +$722K +181,934 +56%
CC
24
Centiva Capital
New York
$2.06M +$543K +136,694 +37%
Balyasny Asset Management
25
Balyasny Asset Management
Illinois
$1.28M +$1.25M +315,240 New
1
2 3 4

ROIV Hedge Fund Activity: Q2 2022 in Review

71 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q2 2022, worth a combined $1.47B — down 15% from $1.72B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ROIV positions and 11 closed out — a net gain of 19 holders — while 22 added to existing stakes and 4 trimmed.

The largest buyer was Two Seas Capital, adding an estimated $10.4M. The largest seller was Millennium Management, exiting entirely with an estimated $693K sold.

  • 71 institutional investors held Roivant Sciences (ROIV) as of Q2 2022, up from 52 in Q1 2022.
  • Funds reported $1.47B of Roivant Sciences stock for Q2 2022, down 15% quarter-over-quarter.
  • 30 funds opened new Roivant Sciences positions in Q2 2022 and 11 closed out, a net change of +19 holders.
  • The largest Roivant Sciences buyer in Q2 2022 was Two Seas Capital, an estimated $10.4M added.
  • The largest Roivant Sciences seller in Q2 2022 was Millennium Management, an estimated $693K sold.

Based on aggregated 13F filings for Q2 2022.